| Primary |
| Breast Cancer |
10.7% |
| Back Pain |
8.0% |
| Intervertebral Disc Protrusion |
6.9% |
| Arthritis |
6.1% |
| Hypersensitivity |
6.1% |
| Hypertension |
5.4% |
| Macular Oedema |
5.4% |
| Multiple Allergies |
5.4% |
| Pain |
4.6% |
| Seasonal Allergy |
4.6% |
| Asthma |
4.2% |
| Dermatitis Contact |
3.8% |
| Eczema |
3.8% |
| Premedication |
3.8% |
| Sinusitis |
3.8% |
| Stomatitis |
3.8% |
| Urticaria |
3.8% |
| Bursitis |
3.4% |
| Arthralgia |
3.1% |
| Plantar Fasciitis |
3.1% |
|
| Injection Site Atrophy |
14.0% |
| Injection Site Reaction |
9.9% |
| Injection Site Pain |
7.2% |
| Muscle Atrophy |
7.2% |
| Weight Decreased |
6.3% |
| Weight Increased |
6.3% |
| Skin Discolouration |
5.0% |
| Skin Disorder |
5.0% |
| Maculopathy |
4.5% |
| Pain |
4.5% |
| Drug Ineffective |
4.1% |
| Urticaria |
3.6% |
| Endophthalmitis |
3.2% |
| Vision Blurred |
3.2% |
| Injection Site Swelling |
2.7% |
| Lipoatrophy |
2.7% |
| Medication Error |
2.7% |
| Menorrhagia |
2.7% |
| Osteitis |
2.7% |
| Swelling Face |
2.7% |
|
| Secondary |
| Rheumatoid Arthritis |
13.9% |
| Pyoderma Gangrenosum |
12.9% |
| Cataract Operation |
10.7% |
| Pain |
10.2% |
| Drug Use For Unknown Indication |
8.5% |
| Product Used For Unknown Indication |
6.3% |
| Arthralgia |
4.4% |
| Breast Cancer Recurrent |
3.4% |
| Depression |
3.4% |
| Arthritis |
2.9% |
| Hypertension |
2.7% |
| Intervertebral Disc Protrusion |
2.7% |
| Choroidal Neovascularisation |
2.4% |
| Macular Degeneration |
2.4% |
| Osteoarthritis |
2.4% |
| Pain In Extremity |
2.4% |
| Back Pain |
2.2% |
| Arthropathy |
2.0% |
| Bursitis |
2.0% |
| Carpal Tunnel Syndrome |
2.0% |
|
| Streptococcal Infection |
14.6% |
| Endophthalmitis |
8.7% |
| Pelvic Pain |
7.8% |
| Visual Acuity Reduced |
7.8% |
| Cushing's Syndrome |
3.9% |
| Drug Ineffective |
3.9% |
| Hirsutism |
3.9% |
| Lipoatrophy |
3.9% |
| Osteitis |
3.9% |
| Rash |
3.9% |
| Skin Discolouration |
3.9% |
| Skin Exfoliation |
3.9% |
| Swelling Face |
3.9% |
| Therapeutic Product Contamination |
3.9% |
| Throat Tightness |
3.9% |
| Urticaria |
3.9% |
| Vaginal Haemorrhage |
3.9% |
| Weight Increased |
3.9% |
| Wound Dehiscence |
3.9% |
| Bone Disorder |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Drug Use For Unknown Indication |
14.6% |
| Prophylaxis |
11.8% |
| Pain |
5.2% |
| Rheumatoid Arthritis |
5.1% |
| Stomatitis |
4.6% |
| Acne |
4.3% |
| Behcet's Syndrome |
4.3% |
| Hypertension |
3.7% |
| Constipation |
3.4% |
| Colorectal Cancer |
3.0% |
| Insomnia |
2.8% |
| Depression |
2.7% |
| Ovarian Cancer Recurrent |
2.3% |
| Anxiety |
2.0% |
| Psoriasis |
2.0% |
| Osteoporosis |
1.9% |
| Rash |
1.9% |
| Metastatic Renal Cell Carcinoma |
1.6% |
| Nausea |
1.6% |
|
| Vomiting |
12.8% |
| White Blood Cell Count Decreased |
7.4% |
| Pyrexia |
7.1% |
| Thrombocytopenia |
7.1% |
| Stomatitis |
6.7% |
| Weight Increased |
6.7% |
| Viral Infection |
5.7% |
| Urinary Tract Infection |
5.1% |
| Interstitial Lung Disease |
4.0% |
| Pneumonia |
4.0% |
| Tumour Invasion |
3.7% |
| Platelet Count Decreased |
3.4% |
| Pulmonary Embolism |
3.4% |
| Sepsis |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Venous Thrombosis Limb |
3.4% |
| Wound Drainage |
3.4% |
| Wound Infection Staphylococcal |
3.4% |
| C-reactive Protein Increased |
3.0% |
| Deep Vein Thrombosis |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Wrong Technique In Drug Usage Process |
100.0% |
|
